SMI
12.534,64
PKT
+79,44
PKT
+0,64
%
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.09.23 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 14.09.23 | Richemont Overweight | Barclays Capital | |
| 13.09.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 13.09.23 | UBS Buy | Goldman Sachs Group Inc. | |
| 12.09.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 12.09.23 | Roche Equal Weight | Barclays Capital | |
| 12.09.23 | Swiss Re Sell | UBS AG | |
| 12.09.23 | Roche Sell | Deutsche Bank AG | |
| 12.09.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 11.09.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 11.09.23 | Givaudan Sell | UBS AG | |
| 08.09.23 | Richemont Market-Perform | Bernstein Research | |
| 08.09.23 | Novartis Buy | Deutsche Bank AG | |
| 07.09.23 | Nestlé Add | Baader Bank | |
| 07.09.23 | Nestlé Underperform | RBC Capital Markets | |
| 07.09.23 | Zurich Insurance Overweight | Barclays Capital | |
| 07.09.23 | Swiss Re Equal Weight | Barclays Capital | |
| 06.09.23 | Givaudan Sell | UBS AG | |
| 06.09.23 | Nestlé Market-Perform | Bernstein Research | |
| 06.09.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 05.09.23 | Givaudan Underperform | Bernstein Research | |
| 05.09.23 | Novartis Buy | Jefferies & Company Inc. | |
| 05.09.23 | Novartis Buy | Deutsche Bank AG | |
| 05.09.23 | Swiss Re Equal Weight | Barclays Capital | |
| 05.09.23 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.09.23 | UBS Overweight | JP Morgan Chase & Co. | |
| 04.09.23 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 01.09.23 | UBS Buy | Deutsche Bank AG | |
| 01.09.23 | Richemont Outperform | RBC Capital Markets | |
| 01.09.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 01.09.23 | Richemont Buy | UBS AG | |
| 01.09.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 01.09.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 01.09.23 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 31.08.23 | Givaudan Sell | UBS AG | |
| 31.08.23 | Roche Sell | Deutsche Bank AG | |
| 31.08.23 | Novartis Buy | Deutsche Bank AG | |
| 31.08.23 | UBS Buy | Deutsche Bank AG | |
| 31.08.23 | UBS Hold | Jefferies & Company Inc. | |
| 31.08.23 | UBS Sector Perform | RBC Capital Markets |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.